Скачать или смотреть NexTrial.ai Demo | Celina: The Agentic AI Orchestration Co-Pilot for Clinical Trial Activation

Celina is the world’s first agentic AI orchestration co-pilot built specifically for clinical trial activation.

This demo shows how NexTrial.ai transforms trial startup from a 120-day manual process into a predictable, protocol-aware, audit-ready workflow driven by intelligence, not paperwork.

What you will see in this demo
1. Setup — AI-Driven Readiness Orchestration

Celina reads the clinical trial protocol end-to-end and orchestrates every readiness requirement:

• Workforce credential and GCP verification
• Facility and equipment validation
• SOP and DUA mapping
• Regulatory dependencies aligned to FDA, ANVISA, and CDSCO
• Real-time Readiness Scorecard

Readiness becomes measurable before contracts are signed.

2. Match — Predictive Eligibility and Optimal Site Selection

Celina connects the right trial to the right physician or site using:

• Predictive patient eligibility
• Enrollment velocity forecasts for 30, 60, and 90 days
• Specialty and demographic fit
• Operational capacity and staffing alignment

Every match includes a Readiness Confidence Index and a First-Patient-In forecast.

3. Activate — Zero-Rejection Packet Automation

Celina auto-generates activation documents and harmonizes all requirements:

• IRB or ethics packet generation
• SOP, ICF, and DUA harmonization
• Protocol-aware activation checklists
• Explainable AI traceability for audit readiness
• First-time submission accuracy under 5 percent rejection

Activation becomes predictable and ≤45 days.

Why it matters

Clinical trial activation is the slowest, most expensive bottleneck in research.
NexTrial.ai replaces manual fragmentation with agentic AI orchestration, predictive modeling, and audit-ready compliance.

Sponsors gain confidence.
CROs gain predictability.
Sites gain revenue.
Patients get access faster.

Learn More

Website: https://nextrial.ai

Book a demo: https://tidycal.com/1v2x5y3/hello-nex...

Contact: [email protected]